-
1
-
-
73949130115
-
Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
-
Klotz L., Zhang L., Lam A., Nam R., Mamedov A., Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010, 28:126-131.
-
(2010)
J Clin Oncol
, vol.28
, pp. 126-131
-
-
Klotz, L.1
Zhang, L.2
Lam, A.3
Nam, R.4
Mamedov, A.5
Loblaw, A.6
-
2
-
-
77951298004
-
Cryotherapy for prostate cancer: ready for prime time?
-
Pisters L.L. Cryotherapy for prostate cancer: ready for prime time?. Curr Opin Urol 2010, 20:218-222.
-
(2010)
Curr Opin Urol
, vol.20
, pp. 218-222
-
-
Pisters, L.L.1
-
4
-
-
27244436839
-
Technology review: high-intensity focused ultrasound for prostate cancer
-
Pickles T., Goldenberg L., Steinhoff G. Technology review: high-intensity focused ultrasound for prostate cancer. Can J Urol 2005, 12:2593-2597.
-
(2005)
Can J Urol
, vol.12
, pp. 2593-2597
-
-
Pickles, T.1
Goldenberg, L.2
Steinhoff, G.3
-
5
-
-
0034891284
-
High dose radiation delivered by intensity-modulated conformal radiotherapy improves the outcome of localized prostate cancer
-
Zelefsky M.J., Fuks Z., Hunt M., Lee H.J., Lombardi D., Ling C.C., et al. High dose radiation delivered by intensity-modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001, 166:876-881.
-
(2001)
J Urol
, vol.166
, pp. 876-881
-
-
Zelefsky, M.J.1
Fuks, Z.2
Hunt, M.3
Lee, H.J.4
Lombardi, D.5
Ling, C.C.6
-
6
-
-
45449093563
-
Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes
-
Zelefsky M.J., Yamada Y., Fuks Z., Zhang Z., Hunt M., Cahlon O., et al. Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys 2008, 71:1028-1033.
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.71
, pp. 1028-1033
-
-
Zelefsky, M.J.1
Yamada, Y.2
Fuks, Z.3
Zhang, Z.4
Hunt, M.5
Cahlon, O.6
-
7
-
-
0036680314
-
Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial
-
Pollack A., Zagars G.K., Starkschall G., Antolak J.A., Lee J.J., Huang E., et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002, 53:1097-1105.
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.53
, pp. 1097-1105
-
-
Pollack, A.1
Zagars, G.K.2
Starkschall, G.3
Antolak, J.A.4
Lee, J.J.5
Huang, E.6
-
8
-
-
49549085535
-
Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer
-
Chan L.W., Xia P., Gottschalk A.R., Akazawa M., Scala M., Pickett B., et al. Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008, 72:69-77.
-
(2008)
Int J Radiat Oncol Biol Phys.
, vol.72
, pp. 69-77
-
-
Chan, L.W.1
Xia, P.2
Gottschalk, A.R.3
Akazawa, M.4
Scala, M.5
Pickett, B.6
-
9
-
-
76449122350
-
Radiation dose-volume effects in radiation-induced rectal injury
-
Michalski J.M., Gay H., Jackson A., Tucker S.L., Deasy J.O. Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys. 2010, 76:S123-S129.
-
(2010)
Int J Radiat Oncol Biol Phys.
, vol.76
-
-
Michalski, J.M.1
Gay, H.2
Jackson, A.3
Tucker, S.L.4
Deasy, J.O.5
-
10
-
-
77958499583
-
Late rectal toxicity on RTOG 94-06: analysis using a mixture lyman model
-
Tucker S.L., Dong L., Bosch W.R., Michalski J., Winter K., Mohan R., et al. Late rectal toxicity on RTOG 94-06: analysis using a mixture lyman model. Int J Radiat Oncol Biol Phys. 2010, 78:1253-1260.
-
(2010)
Int J Radiat Oncol Biol Phys.
, vol.78
, pp. 1253-1260
-
-
Tucker, S.L.1
Dong, L.2
Bosch, W.R.3
Michalski, J.4
Winter, K.5
Mohan, R.6
-
11
-
-
79955596938
-
Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer
-
[in press]. doi:10.1016/j.ijrobp.2010.02.040
-
Sharma NK, Li T, Chen DY, Pollack A, Horwitz EM, Buyyounouski MK. Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2010; [in press]. doi:10.1016/j.ijrobp.2010.02.040.
-
(2010)
Int J Radiat Oncol Biol Phys
-
-
Sharma, N.K.1
Li, T.2
Chen, D.Y.3
Pollack, A.4
Horwitz, E.M.5
Buyyounouski, M.K.6
-
12
-
-
0015474752
-
Retropubic implantation to iodine 125 in the treatment of prostatic cancer
-
Whitmore W.F., Hilaris B., Grabstald H. Retropubic implantation to iodine 125 in the treatment of prostatic cancer. J Urol. 1972, 108:918-920.
-
(1972)
J Urol.
, vol.108
, pp. 918-920
-
-
Whitmore, W.F.1
Hilaris, B.2
Grabstald, H.3
-
13
-
-
0030764130
-
Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma
-
Ragde H., Blasko J.C., Grimm P.D., Kenny G.M., Sylvester J.E., Hoak D.C., et al. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer. 1997, 80:442-453.
-
(1997)
Cancer.
, vol.80
, pp. 442-453
-
-
Ragde, H.1
Blasko, J.C.2
Grimm, P.D.3
Kenny, G.M.4
Sylvester, J.E.5
Hoak, D.C.6
-
14
-
-
33645101180
-
Relationship of the international prostate symptom score with urinary flow studies, and catheterization rates following 125I prostate brachytherapy
-
Martens C., Pond G., Webster D., McLean M., Gillan C., Crook J. Relationship of the international prostate symptom score with urinary flow studies, and catheterization rates following 125I prostate brachytherapy. Brachytherapy. 2006, 5:9-13.
-
(2006)
Brachytherapy.
, vol.5
, pp. 9-13
-
-
Martens, C.1
Pond, G.2
Webster, D.3
McLean, M.4
Gillan, C.5
Crook, J.6
-
15
-
-
0036471475
-
Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation
-
Crook J., McLean M., Catton C., Yeung I., Tsihlias J., Pintilie M. Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. Int J Radiat Oncol Biol Phys. 2002, 52:453-460.
-
(2002)
Int J Radiat Oncol Biol Phys.
, vol.52
, pp. 453-460
-
-
Crook, J.1
McLean, M.2
Catton, C.3
Yeung, I.4
Tsihlias, J.5
Pintilie, M.6
-
16
-
-
0036499149
-
Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: A prospective study
-
Locke J., Ellis W., Wallner K., Cavanagh W., Blasko J. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: A prospective study. Int J Radiat Oncol Biol Phys. 2002, 52:712-719.
-
(2002)
Int J Radiat Oncol Biol Phys.
, vol.52
, pp. 712-719
-
-
Locke, J.1
Ellis, W.2
Wallner, K.3
Cavanagh, W.4
Blasko, J.5
-
17
-
-
0034564113
-
Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy
-
Lee N., Wuu C.S., Brody R., Laguna J.L., Katz A.E., Bagiella E., et al. Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2000, 48:1457-1460.
-
(2000)
Int J Radiat Oncol Biol Phys.
, vol.48
, pp. 1457-1460
-
-
Lee, N.1
Wuu, C.S.2
Brody, R.3
Laguna, J.L.4
Katz, A.E.5
Bagiella, E.6
-
18
-
-
1542398900
-
Toxicity and early biochemical outcomes from 125iodine prostate brachytherapy in the UK. A prospective study
-
Henderson A., Ismail A.K., Cunningham M., Aldridge S., Loverock L., Langley S.E., et al. Toxicity and early biochemical outcomes from 125iodine prostate brachytherapy in the UK. A prospective study. Clin Oncol (R Coll Radiol) 2004, 16:95-104.
-
(2004)
Clin Oncol (R Coll Radiol)
, vol.16
, pp. 95-104
-
-
Henderson, A.1
Ismail, A.K.2
Cunningham, M.3
Aldridge, S.4
Loverock, L.5
Langley, S.E.6
-
19
-
-
33645886947
-
Prediction of urinary symptoms after 125iodine prostate brachytherapy
-
Kelly K., Swindell R., Routledge J., Burns M., Logue J.P., Wylie J.P. Prediction of urinary symptoms after 125iodine prostate brachytherapy. Clin Oncol (R Coll Radiol). 2006, 18:326-332.
-
(2006)
Clin Oncol (R Coll Radiol).
, vol.18
, pp. 326-332
-
-
Kelly, K.1
Swindell, R.2
Routledge, J.3
Burns, M.4
Logue, J.P.5
Wylie, J.P.6
-
20
-
-
70349559785
-
Urinary symptom flare in 712 125I prostate brachytherapy patients: long-term follow-up
-
Keyes M., Miller S., Moravan V., Pickles T., Liu M., Spadinger I., et al. Urinary symptom flare in 712 125I prostate brachytherapy patients: long-term follow-up. Int J Radiat Oncol Biol Phys. 2009, 75:649-655.
-
(2009)
Int J Radiat Oncol Biol Phys.
, vol.75
, pp. 649-655
-
-
Keyes, M.1
Miller, S.2
Moravan, V.3
Pickles, T.4
Liu, M.5
Spadinger, I.6
-
21
-
-
34648843753
-
Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy
-
Mabjeesh N.J., Chen J., Stenger A., Matzkin H. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy. Urology. 2007, 70:548-553.
-
(2007)
Urology.
, vol.70
, pp. 548-553
-
-
Mabjeesh, N.J.1
Chen, J.2
Stenger, A.3
Matzkin, H.4
-
22
-
-
0026591918
-
The american urological association symptom index for benign prostatic hyperplasia. the measurement committee of the american urological association
-
[discussion 1564]
-
Barry M.J., Fowler F.J., O'Leary M.P., Bruskewitz R.C., Holtgrewe H.L., Mebust W.K., et al. The american urological association symptom index for benign prostatic hyperplasia. the measurement committee of the american urological association. J Urol. 1992, 148:1549-1557. [discussion 1564].
-
(1992)
J Urol.
, vol.148
, pp. 1549-1557
-
-
Barry, M.J.1
Fowler, F.J.2
O'Leary, M.P.3
Bruskewitz, R.C.4
Holtgrewe, H.L.5
Mebust, W.K.6
-
23
-
-
28844494984
-
Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis
-
Merrick G.S., Butler W.M., Wallner K.E., Blasko J.C., Michalski J., Aronowitz J., et al. Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis. Brachytherapy. 2005, 4:241-251.
-
(2005)
Brachytherapy.
, vol.4
, pp. 241-251
-
-
Merrick, G.S.1
Butler, W.M.2
Wallner, K.E.3
Blasko, J.C.4
Michalski, J.5
Aronowitz, J.6
-
24
-
-
0038075456
-
Prostate brachytherapy seed identification on post-implant TRUS images
-
Han B.H., Wallner K., Merrick G., Butler W., Sutlief S., Sylvester J. Prostate brachytherapy seed identification on post-implant TRUS images. Med Phys. 2003, 30:898-900.
-
(2003)
Med Phys.
, vol.30
, pp. 898-900
-
-
Han, B.H.1
Wallner, K.2
Merrick, G.3
Butler, W.4
Sutlief, S.5
Sylvester, J.6
-
25
-
-
37049023855
-
Comparison of real-time intraoperative ultrasound-based dosimetry with postoperative computed tomography-based dosimetry for prostate brachytherapy
-
Nag S., Shi P., Liu B., Gupta N., Bahnson R.R., Wang J.Z. Comparison of real-time intraoperative ultrasound-based dosimetry with postoperative computed tomography-based dosimetry for prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2008, 70:311-317.
-
(2008)
Int J Radiat Oncol Biol Phys.
, vol.70
, pp. 311-317
-
-
Nag, S.1
Shi, P.2
Liu, B.3
Gupta, N.4
Bahnson, R.R.5
Wang, J.Z.6
-
26
-
-
77954959954
-
Differences between intraoperative ultrasound-based dosimetry and postoperative computed tomography-based dosimetry for permanent interstitial prostate brachytherapy
-
Ishiyama H., Nakamura R., Satoh T., Tanji S., Uemae M., Baba S., et al. Differences between intraoperative ultrasound-based dosimetry and postoperative computed tomography-based dosimetry for permanent interstitial prostate brachytherapy. Brachytherapy. 2010, 9:219-223.
-
(2010)
Brachytherapy.
, vol.9
, pp. 219-223
-
-
Ishiyama, H.1
Nakamura, R.2
Satoh, T.3
Tanji, S.4
Uemae, M.5
Baba, S.6
-
27
-
-
57749169963
-
Comparison between real-time intraoperative ultrasound-based dosimetry and CT-based dosimetry for prostate brachytherapy using cesium-131
-
Jacobs B.L., Gibbons E.P., Smith R.P., Beriwal S., Komanduri K., Benoit R.M. Comparison between real-time intraoperative ultrasound-based dosimetry and CT-based dosimetry for prostate brachytherapy using cesium-131. Technol Cancer Res Treat. 2008, 7:463-469.
-
(2008)
Technol Cancer Res Treat.
, vol.7
, pp. 463-469
-
-
Jacobs, B.L.1
Gibbons, E.P.2
Smith, R.P.3
Beriwal, S.4
Komanduri, K.5
Benoit, R.M.6
-
28
-
-
70350712610
-
AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of task group 137
-
Nath R., Bice W.S., Butler W.M., Chen Z., Meigooni A.S., Narayana V., et al. AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of task group 137. Med Phys. 2009, 36:5310-5322.
-
(2009)
Med Phys.
, vol.36
, pp. 5310-5322
-
-
Nath, R.1
Bice, W.S.2
Butler, W.M.3
Chen, Z.4
Meigooni, A.S.5
Narayana, V.6
-
29
-
-
33646267933
-
Rectal-wall dose dependence on postplan timing after permanent seed prostate brachytherapy
-
Taussky D., Yeung I., Williams T., Pearson S., McLean M., Pond G., et al. Rectal-wall dose dependence on postplan timing after permanent seed prostate brachytherapy. Radiat Oncol Biol Phys. 2006, 65:358-363.
-
(2006)
Radiat Oncol Biol Phys.
, vol.65
, pp. 358-363
-
-
Taussky, D.1
Yeung, I.2
Williams, T.3
Pearson, S.4
McLean, M.5
Pond, G.6
-
30
-
-
29244461411
-
Comparison of day 0 and day 14 dosimetry for permanent prostate implants using stranded seeds
-
McLaughlin P., Narayana V., Pan C., Berri S., Troyer S., Herman J., et al. Comparison of day 0 and day 14 dosimetry for permanent prostate implants using stranded seeds. Int J Radiat Oncol Biol Phys. 2006, 64:144-150.
-
(2006)
Int J Radiat Oncol Biol Phys.
, vol.64
, pp. 144-150
-
-
McLaughlin, P.1
Narayana, V.2
Pan, C.3
Berri, S.4
Troyer, S.5
Herman, J.6
-
31
-
-
57649112761
-
Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer
-
Saibishkumar E.P., Borg J., Yeung I., Cummins-Holder C., Landon A., Crook J. Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2009, 73:61-68.
-
(2009)
Int J Radiat Oncol Biol Phys.
, vol.73
, pp. 61-68
-
-
Saibishkumar, E.P.1
Borg, J.2
Yeung, I.3
Cummins-Holder, C.4
Landon, A.5
Crook, J.6
-
32
-
-
21244455123
-
Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion
-
Taussky D., Austen L., Toi A., Yeung I., Williams T., Pearson S., et al. Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion. Int J Radiat Oncol Biol Phys. 2005, 62:974-980.
-
(2005)
Int J Radiat Oncol Biol Phys.
, vol.62
, pp. 974-980
-
-
Taussky, D.1
Austen, L.2
Toi, A.3
Yeung, I.4
Williams, T.5
Pearson, S.6
-
33
-
-
0344234456
-
Importance of implant dosimetry for patients undergoing prostate brachytherapy
-
Potters L., Huang D., Calugaru E., Fearn P., Lee L., Kattan M.W. Importance of implant dosimetry for patients undergoing prostate brachytherapy. Urology. 2003, 62:1073-1077.
-
(2003)
Urology.
, vol.62
, pp. 1073-1077
-
-
Potters, L.1
Huang, D.2
Calugaru, E.3
Fearn, P.4
Lee, L.5
Kattan, M.W.6
-
34
-
-
30544440136
-
Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results
-
Stock R.G., Stone N.N., Cesaretti J.A., Rosenstein B.S. Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results. Int J Radiat Oncol Biol Phys. 2006, 64:527-533.
-
(2006)
Int J Radiat Oncol Biol Phys.
, vol.64
, pp. 527-533
-
-
Stock, R.G.1
Stone, N.N.2
Cesaretti, J.A.3
Rosenstein, B.S.4
-
35
-
-
37049020446
-
(125)I monotherapy using D90 implant doses of 180gy or greater
-
Kao J., Stone N.N., Lavaf A., Dumane V., Cesaretti J.A., Stock R.G. (125)I monotherapy using D90 implant doses of 180gy or greater. Int J Radiat Oncol Biol Phys. 2008, 70:96-101.
-
(2008)
Int J Radiat Oncol Biol Phys.
, vol.70
, pp. 96-101
-
-
Kao, J.1
Stone, N.N.2
Lavaf, A.3
Dumane, V.4
Cesaretti, J.A.5
Stock, R.G.6
-
36
-
-
77956535585
-
Biochemical disease-free rate and toxicity for men treated with iodine-125 prostate brachytherapy with d(90)≥180gy
-
Gomez-Iturriaga Pina A., Crook J., Borg J., Ma C. Biochemical disease-free rate and toxicity for men treated with iodine-125 prostate brachytherapy with d(90)≥180gy. Int J Radiat Oncol Biol Phys. 2010, 78:422-427.
-
(2010)
Int J Radiat Oncol Biol Phys.
, vol.78
, pp. 422-427
-
-
Gomez-Iturriaga Pina, A.1
Crook, J.2
Borg, J.3
Ma, C.4
-
37
-
-
25144518567
-
Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk
-
Crook J.M., Potters L., Stock R.G., Zelefsky M.J. Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk. Brachytherapy. 2005, 4:186-194.
-
(2005)
Brachytherapy.
, vol.4
, pp. 186-194
-
-
Crook, J.M.1
Potters, L.2
Stock, R.G.3
Zelefsky, M.J.4
-
38
-
-
0035371057
-
Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis
-
Snyder K.M., Stock R.G., Hong S.M., Lo Y.C., Stone N.N. Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2001, 50:335-341.
-
(2001)
Int J Radiat Oncol Biol Phys.
, vol.50
, pp. 335-341
-
-
Snyder, K.M.1
Stock, R.G.2
Hong, S.M.3
Lo, Y.C.4
Stone, N.N.5
-
39
-
-
0042383238
-
Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer
-
Lee H.K., D'Souza W.D., Yamal J.M., Pollack A., Lee A.K., Palmer M.B., et al. Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2003, 57:355-361.
-
(2003)
Int J Radiat Oncol Biol Phys.
, vol.57
, pp. 355-361
-
-
Lee, H.K.1
D'Souza, W.D.2
Yamal, J.M.3
Pollack, A.4
Lee, A.K.5
Palmer, M.B.6
-
40
-
-
33646940462
-
Radiation dose to the internal pudendal arteries from permanent-seed prostate brachytherapy as determined by time-of-flight MR angiography
-
Gillan C., Kirilova A., Landon A., Yeung I., Pond G., Crook J. Radiation dose to the internal pudendal arteries from permanent-seed prostate brachytherapy as determined by time-of-flight MR angiography. Int J Radiat Oncol Biol Phys. 2006, 65:688-693.
-
(2006)
Int J Radiat Oncol Biol Phys.
, vol.65
, pp. 688-693
-
-
Gillan, C.1
Kirilova, A.2
Landon, A.3
Yeung, I.4
Pond, G.5
Crook, J.6
-
41
-
-
0034653304
-
Brachytherapy radiation doses to the neurovascular bundles
-
DiBiase S.J., Wallner K., Tralins K., Sutlief S. Brachytherapy radiation doses to the neurovascular bundles. Int J Radiat Oncol Biol Phys. 2000, 46:1301-1307.
-
(2000)
Int J Radiat Oncol Biol Phys.
, vol.46
, pp. 1301-1307
-
-
DiBiase, S.J.1
Wallner, K.2
Tralins, K.3
Sutlief, S.4
-
42
-
-
79956213141
-
Lack of significant intraprostatic migration of stranded iodine-125 sources in prostate brachytherapy implants
-
[in press]. doi:10.1016/j.brachy.2010.10.001
-
Usmani N, Chng N, Spadinger I, Morris WJ. Lack of significant intraprostatic migration of stranded iodine-125 sources in prostate brachytherapy implants. Brachytherapy 2010; [in press]. doi:10.1016/j.brachy.2010.10.001.
-
(2010)
Brachytherapy
-
-
Usmani, N.1
Chng, N.2
Spadinger, I.3
Morris, W.J.4
-
43
-
-
73649141319
-
Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy
-
McLaughlin P.W., Evans C., Feng M., Narayana V. Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy. Int J Radiat Oncol Biol Phys. 2010, 76:369-378.
-
(2010)
Int J Radiat Oncol Biol Phys.
, vol.76
, pp. 369-378
-
-
McLaughlin, P.W.1
Evans, C.2
Feng, M.3
Narayana, V.4
-
44
-
-
10744220937
-
Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy
-
Crook J., Milosevic M., Catton P., Yeung I., Haycocks T., Tran T., et al. Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy. Brachytherapy. 2002, 1:66-73.
-
(2002)
Brachytherapy.
, vol.1
, pp. 66-73
-
-
Crook, J.1
Milosevic, M.2
Catton, P.3
Yeung, I.4
Haycocks, T.5
Tran, T.6
-
45
-
-
33847333327
-
Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR
-
Smith W.L., Lewis C., Bauman G., Rodrigues G., D'Souza D., Ash R., et al. Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR. Int J Radiat Oncol Biol Phys. 2007, 67:1238-1247.
-
(2007)
Int J Radiat Oncol Biol Phys.
, vol.67
, pp. 1238-1247
-
-
Smith, W.L.1
Lewis, C.2
Bauman, G.3
Rodrigues, G.4
D'Souza, D.5
Ash, R.6
-
46
-
-
79956196511
-
-
Implications of CT-imaging for post plan quality assessment (QA) in prostate brachytherapy (BT) (poster). ESTRO 29; September 12-16, 2010; Barcelona, Spain;
-
Petrik D, Crook J, Araujo C, Halperin R, Kim D. In: Implications of CT-imaging for post plan quality assessment (QA) in prostate brachytherapy (BT) (poster). ESTRO 29; September 12-16, 2010; Barcelona, Spain; 2010. p. S216.
-
(2010)
-
-
Petrik, D.1
Crook, J.2
Araujo, C.3
Halperin, R.4
Kim, D.5
-
47
-
-
77953547920
-
Magnetic resonance imaging-defined treatment margins in iodine-125 prostate brachytherapy
-
Crook J., Patil N., Ma C., McLean M., Borg J. Magnetic resonance imaging-defined treatment margins in iodine-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2010, 77:1079-1084.
-
(2010)
Int J Radiat Oncol Biol Phys.
, vol.77
, pp. 1079-1084
-
-
Crook, J.1
Patil, N.2
Ma, C.3
McLean, M.4
Borg, J.5
-
48
-
-
79960077352
-
10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients
-
[in press]. doi:10.1016/j.ijrobp.2010.04.038
-
Crook J, Borg J, Evans A, Toi A, Saibishkumar EP, Fung S, et al. 10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients. Int J Radiat Oncol Biol Phys 2010; [in press]. doi:10.1016/j.ijrobp.2010.04.038.
-
(2010)
Int J Radiat Oncol Biol Phys
-
-
Crook, J.1
Borg, J.2
Evans, A.3
Toi, A.4
Saibishkumar, E.P.5
Fung, S.6
-
49
-
-
4644354413
-
Iodine 125 versus palladium 103 implants for prostate cancer: clinical outcomes and complications
-
Peschel R.E, Colberg J.W., Chen Z., Nath R., Wilson L.D. Iodine 125 versus palladium 103 implants for prostate cancer: clinical outcomes and complications. Cancer J 2004, 10:170-174.
-
(2004)
Cancer J
, vol.10
, pp. 170-174
-
-
Peschel, R.E.1
Colberg, J.W.2
Chen, Z.3
Nath, R.4
Wilson, L.D.5
-
50
-
-
0344395011
-
125I versus 103Pd for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial
-
Wallner K., Merrick G., True L., Sutlief S., Cavanagh W., Butler W. 125I versus 103Pd for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial. Int J Radiat Oncol Biol Phys 2003, 57:1297-1303.
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.57
, pp. 1297-1303
-
-
Wallner, K.1
Merrick, G.2
True, L.3
Sutlief, S.4
Cavanagh, W.5
Butler, W.6
-
51
-
-
79956208938
-
Predictors of urinary morbidity in cs-131 prostate brachytherapy implants
-
[in press]. doi:10.1016/j.ijrobp.2010.06.017
-
Smith RP, Jones HA, Beriwal S, Gokhale A, Benoit R. Predictors of urinary morbidity in cs-131 prostate brachytherapy implants. Int J Radiat Oncol Biol Phys 2010, [in press]. doi:10.1016/j.ijrobp.2010.06.017.
-
(2010)
Int J Radiat Oncol Biol Phys
-
-
Smith, R.P.1
Jones, H.A.2
Beriwal, S.3
Gokhale, A.4
Benoit, R.5
-
52
-
-
79952276881
-
Cesium 131 versus iodine 125 implants for prostate cancer: evaluation of early PSA response
-
Tomaszewski J.J, Smaldone M.C., Makaroun S., Smith R.P., Beriwal S., Benoit R.M. Cesium 131 versus iodine 125 implants for prostate cancer: evaluation of early PSA response. Can J Urol 2010, 17:5360-5364.
-
(2010)
Can J Urol
, vol.17
, pp. 5360-5364
-
-
Tomaszewski, J.J.1
Smaldone, M.C.2
Makaroun, S.3
Smith, R.P.4
Beriwal, S.5
Benoit, R.M.6
-
53
-
-
78651418246
-
Acute bowel morbidity after prostate brachytherapy with cesium-131
-
Jacobs B.L., Gibbons E.P., Smith R.P., Beriwal S., Benoit R.M. Acute bowel morbidity after prostate brachytherapy with cesium-131. Brachytherapy 2011, 10:51-56.
-
(2011)
Brachytherapy
, vol.10
, pp. 51-56
-
-
Jacobs, B.L.1
Gibbons, E.P.2
Smith, R.P.3
Beriwal, S.4
Benoit, R.M.5
-
54
-
-
67349130809
-
Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapy
-
Stock R.G., Klein T.J., Cesaretti J.A., Stone N.N. Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2009, 74:753-758.
-
(2009)
Int J Radiat Oncol Biol Phys.
, vol.74
, pp. 753-758
-
-
Stock, R.G.1
Klein, T.J.2
Cesaretti, J.A.3
Stone, N.N.4
-
55
-
-
0035450305
-
10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy
-
Grimm P.D., Blasko J.C., Sylvester J.E., Meier R.M., Cavanagh W. 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. Int J Radiat Oncol Biol Phys. 2001, 51:31-40.
-
(2001)
Int J Radiat Oncol Biol Phys.
, vol.51
, pp. 31-40
-
-
Grimm, P.D.1
Blasko, J.C.2
Sylvester, J.E.3
Meier, R.M.4
Cavanagh, W.5
-
56
-
-
73649090388
-
Local control following permanent prostate brachytherapy: effect of high biologically effective dose on biopsy results and oncologic outcomes
-
Stone N.N., Stock R.G., Cesaretti J.A., Unger P. Local control following permanent prostate brachytherapy: effect of high biologically effective dose on biopsy results and oncologic outcomes. Int J Radiat Oncol Biol Phys. 2010, 76:355-360.
-
(2010)
Int J Radiat Oncol Biol Phys.
, vol.76
, pp. 355-360
-
-
Stone, N.N.1
Stock, R.G.2
Cesaretti, J.A.3
Unger, P.4
-
57
-
-
34147146526
-
Patterns of local failure following prostate brachytherapy
-
[discussion 1763-4]
-
Stone N.N., Stock R.G., White I., Unger P. Patterns of local failure following prostate brachytherapy. J Urol. 2007, 177:1759-1763. [discussion 1763-4].
-
(2007)
J Urol.
, vol.177
, pp. 1759-1763
-
-
Stone, N.N.1
Stock, R.G.2
White, I.3
Unger, P.4
-
58
-
-
63149196150
-
Population-based study of biochemical and survival outcomes after permanent 125I brachytherapy for low- and intermediate-risk prostate cancer
-
[discussion 865-7]
-
Morris W.J., Keyes M., Palma D., Spadinger I., McKenzie M.R., Agranovich A., et al. Population-based study of biochemical and survival outcomes after permanent 125I brachytherapy for low- and intermediate-risk prostate cancer. Urology. 2009, 73:860-865. [discussion 865-7].
-
(2009)
Urology.
, vol.73
, pp. 860-865
-
-
Morris, W.J.1
Keyes, M.2
Palma, D.3
Spadinger, I.4
McKenzie, M.R.5
Agranovich, A.6
-
59
-
-
0242523827
-
No apparent benefit at 5years from a course of neoadjuvant/concurrent androgen deprivation for patients with prostate cancer treated with a high total radiation dose
-
Martinez A., Galalae R., Gonzalez J., Mitchell C., Gustafson G., Kovacs G. No apparent benefit at 5years from a course of neoadjuvant/concurrent androgen deprivation for patients with prostate cancer treated with a high total radiation dose. J Urol. 2003, 170:2296-2301.
-
(2003)
J Urol.
, vol.170
, pp. 2296-2301
-
-
Martinez, A.1
Galalae, R.2
Gonzalez, J.3
Mitchell, C.4
Gustafson, G.5
Kovacs, G.6
-
60
-
-
79959331135
-
Lack of benefit for the addition of androgen deprivation therapy to dose-escalated radiotherapy in the treatment of intermediate- and high-risk prostate cancer
-
[in press]. doi:10.1016/j.ijrobp.2010.04.004
-
Krauss D, Kestin L, Ye H, Brabbins D, Ghilezan M, Gustafson G, et al. Lack of benefit for the addition of androgen deprivation therapy to dose-escalated radiotherapy in the treatment of intermediate- and high-risk prostate cancer. Int J Radiat Oncol Biol Phys 2010; [in press]. doi:10.1016/j.ijrobp.2010.04.004.
-
(2010)
Int J Radiat Oncol Biol Phys
-
-
Krauss, D.1
Kestin, L.2
Ye, H.3
Brabbins, D.4
Ghilezan, M.5
Gustafson, G.6
-
61
-
-
77952552938
-
Clinical outcome of intermediate risk prostate cancer treated with iodine 125 monotherapy: the Hotel-Dieu of Quebec experience
-
Zebentout O, Apardian R., Beaulieu L., Harel F., Martin A.G., Vigneault E. Clinical outcome of intermediate risk prostate cancer treated with iodine 125 monotherapy: the Hotel-Dieu of Quebec experience. Cancer Radiother 2010, 14:183-188.
-
(2010)
Cancer Radiother
, vol.14
, pp. 183-188
-
-
Zebentout, O.1
Apardian, R.2
Beaulieu, L.3
Harel, F.4
Martin, A.G.5
Vigneault, E.6
-
62
-
-
58149327450
-
Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy
-
Stone N.N., Potters L., Davis B.J., Ciezki J.P., Zelefsky M.J., Roach M., et al. Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2009, 73:341-346.
-
(2009)
Int J Radiat Oncol Biol Phys.
, vol.73
, pp. 341-346
-
-
Stone, N.N.1
Potters, L.2
Davis, B.J.3
Ciezki, J.P.4
Zelefsky, M.J.5
Roach, M.6
-
63
-
-
36749054178
-
Long-term urinary sequelae following 125iodine prostate brachytherapy
-
[discussion 146]
-
Crook J., Fleshner N., Roberts C., Pond G. Long-term urinary sequelae following 125iodine prostate brachytherapy. J Urol. 2008, 179:141-145. [discussion 146].
-
(2008)
J Urol.
, vol.179
, pp. 141-145
-
-
Crook, J.1
Fleshner, N.2
Roberts, C.3
Pond, G.4
-
64
-
-
40249102397
-
Acute and late urinary toxicity in 606 prostate brachytherapy patients
-
Keyes M., Miller S., Moravan V., Kwan W., Liu M., Morris J., et al. Acute and late urinary toxicity in 606 prostate brachytherapy patients. Radiother Oncol. 2006, 80:S41-A141.
-
(2006)
Radiother Oncol.
, vol.80
-
-
Keyes, M.1
Miller, S.2
Moravan, V.3
Kwan, W.4
Liu, M.5
Morris, J.6
-
65
-
-
61349085409
-
Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients
-
Keyes M., Miller S., Moravan V., Pickles T., McKenzie M., Pai H., et al. Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients. Int J Radiat Oncol Biol Phys. 2009, 73:1023-1032.
-
(2009)
Int J Radiat Oncol Biol Phys.
, vol.73
, pp. 1023-1032
-
-
Keyes, M.1
Miller, S.2
Moravan, V.3
Pickles, T.4
McKenzie, M.5
Pai, H.6
-
66
-
-
79952705360
-
Long-term outcome for clinically localized prostate cancer treated with permanent interstitial brachytherapy
-
Taira A.V., Merrick G.S., Butler W.M., Galbreath R.W., Lief J., Adamovich E., et al. Long-term outcome for clinically localized prostate cancer treated with permanent interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2011, 79:1336-1342.
-
(2011)
Int J Radiat Oncol Biol Phys.
, vol.79
, pp. 1336-1342
-
-
Taira, A.V.1
Merrick, G.S.2
Butler, W.M.3
Galbreath, R.W.4
Lief, J.5
Adamovich, E.6
-
67
-
-
0031036150
-
Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma
-
Crook J.M., Bahadur Y.A., Robertson S.J., Perry G.A., Esche B.A. Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma. Cancer. 1997, 79:81-89.
-
(1997)
Cancer.
, vol.79
, pp. 81-89
-
-
Crook, J.M.1
Bahadur, Y.A.2
Robertson, S.J.3
Perry, G.A.4
Esche, B.A.5
-
68
-
-
0141449256
-
Clinical correlates to PSA spikes and positive repeat biopsies after prostate brachytherapy
-
Reed D., Wallner K., Merrick G., Buskirk S., True L. Clinical correlates to PSA spikes and positive repeat biopsies after prostate brachytherapy. Urology. 2003, 62:683-688.
-
(2003)
Urology.
, vol.62
, pp. 683-688
-
-
Reed, D.1
Wallner, K.2
Merrick, G.3
Buskirk, S.4
True, L.5
-
69
-
-
34548497179
-
PSA kinetics and PSA bounce following permanent seed prostate brachytherapy
-
Crook J., Gillan C., Yeung I., Austen L., McLean M., Lockwood G., et al. PSA kinetics and PSA bounce following permanent seed prostate brachytherapy. Radiat Oncol Biol Phys. 2007, 69:426-433.
-
(2007)
Radiat Oncol Biol Phys.
, vol.69
, pp. 426-433
-
-
Crook, J.1
Gillan, C.2
Yeung, I.3
Austen, L.4
McLean, M.5
Lockwood, G.6
-
70
-
-
30544454901
-
PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time
-
Ciezki J.P., Reddy C.A., Garcia J., Angermeier K., Ulchaker J., Mahadevan A., et al. PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time. Int J Radiat Oncol Biol Phys. 2006, 64:512-517.
-
(2006)
Int J Radiat Oncol Biol Phys.
, vol.64
, pp. 512-517
-
-
Ciezki, J.P.1
Reddy, C.A.2
Garcia, J.3
Angermeier, K.4
Ulchaker, J.5
Mahadevan, A.6
-
71
-
-
33749639088
-
Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis
-
Horwitz E.M., Levy L.B., Thames H.D., Kupelian P.A., Martinez A.A., Michalski J.M., et al. Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis. Cancer. 2006, 107:1496-1502.
-
(2006)
Cancer.
, vol.107
, pp. 1496-1502
-
-
Horwitz, E.M.1
Levy, L.B.2
Thames, H.D.3
Kupelian, P.A.4
Martinez, A.A.5
Michalski, J.M.6
-
72
-
-
77952744809
-
Median 5-year follow-up of (125)iodine brachytherapy as monotherapy in men aged≤55years with favorable prostate cancer
-
Gomez-Iturriaga Pina A., Crook J., Borg J., Lockwood G., Fleshner N. Median 5-year follow-up of (125)iodine brachytherapy as monotherapy in men aged≤55years with favorable prostate cancer. Urology 2010, 75:1412-1416.
-
(2010)
Urology
, vol.75
, pp. 1412-1416
-
-
Gomez-Iturriaga Pina, A.1
Crook, J.2
Borg, J.3
Lockwood, G.4
Fleshner, N.5
-
73
-
-
59849088946
-
An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome
-
Bachand F., Martin A.G., Beaulieu L., Harel F., Vigneault E. An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome. Int J Radiat Oncol Biol Phys. 2009, 73:679-684.
-
(2009)
Int J Radiat Oncol Biol Phys.
, vol.73
, pp. 679-684
-
-
Bachand, F.1
Martin, A.G.2
Beaulieu, L.3
Harel, F.4
Vigneault, E.5
-
74
-
-
54049137994
-
High-dose-rate brachytherapy of a single implant with two fractions combined with external beam radiotherapy for hormone-naive prostate cancer
-
Sato M., Mori T., Shirai S., Kishi K., Inagaki T., Hara I. High-dose-rate brachytherapy of a single implant with two fractions combined with external beam radiotherapy for hormone-naive prostate cancer. Int J Radiat Oncol Biol Phys. 2008, 72:1002-1009.
-
(2008)
Int J Radiat Oncol Biol Phys.
, vol.72
, pp. 1002-1009
-
-
Sato, M.1
Mori, T.2
Shirai, S.3
Kishi, K.4
Inagaki, T.5
Hara, I.6
-
75
-
-
34548043496
-
Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: mature prospective phase I/II study results
-
Duchesne G.M., Williams S.G., Das R., Tai K.H. Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: mature prospective phase I/II study results. Radiother Oncol. 2007, 84:128-134.
-
(2007)
Radiother Oncol.
, vol.84
, pp. 128-134
-
-
Duchesne, G.M.1
Williams, S.G.2
Das, R.3
Tai, K.H.4
-
76
-
-
16344388273
-
High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results
-
Demanes D.J., Rodriguez R.R., Schour L., Brandt D., Altieri G. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys. 2005, 61:1306-1316.
-
(2005)
Int J Radiat Oncol Biol Phys.
, vol.61
, pp. 1306-1316
-
-
Demanes, D.J.1
Rodriguez, R.R.2
Schour, L.3
Brandt, D.4
Altieri, G.5
-
77
-
-
12144291223
-
Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer
-
Galalae R.M., Martinez A., Mate T., Mitchell C., Edmundson G., Nuernberg N., et al. Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2004, 58:1048-1055.
-
(2004)
Int J Radiat Oncol Biol Phys.
, vol.58
, pp. 1048-1055
-
-
Galalae, R.M.1
Martinez, A.2
Mate, T.3
Mitchell, C.4
Edmundson, G.5
Nuernberg, N.6
-
78
-
-
0031060205
-
Brachytherapy for penile cancer using silicon mold
-
Akimoto T., Mitsuhashi N., Takahashi I., Yonome I., Takahashi M., Hayakawa K., et al. Brachytherapy for penile cancer using silicon mold. Oncology. 1997, 54:23-27.
-
(1997)
Oncology.
, vol.54
, pp. 23-27
-
-
Akimoto, T.1
Mitsuhashi, N.2
Takahashi, I.3
Yonome, I.4
Takahashi, M.5
Hayakawa, K.6
-
79
-
-
0031779940
-
High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report
-
Mate T.P., Gottesman J.E., Hatton J., Gribble M., Van Hollebeke L. High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report. Int J Radiat Oncol Biol Phys. 1998, 41:525-533.
-
(1998)
Int J Radiat Oncol Biol Phys.
, vol.41
, pp. 525-533
-
-
Mate, T.P.1
Gottesman, J.E.2
Hatton, J.3
Gribble, M.4
Van Hollebeke, L.5
-
80
-
-
22144492906
-
Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime
-
Martinez A.A., Demanes D.J., Galalae R., Vargas C., Bertermann H., Rodriguez R., et al. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime. Int J Radiat Oncol Biol Phys. 2005, 62:1322-1331.
-
(2005)
Int J Radiat Oncol Biol Phys.
, vol.62
, pp. 1322-1331
-
-
Martinez, A.A.1
Demanes, D.J.2
Galalae, R.3
Vargas, C.4
Bertermann, H.5
Rodriguez, R.6
-
81
-
-
14744292134
-
Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer
-
Astrom L., Pedersen D., Mercke C., Holmang S., Johansson K.A. Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer. Radiother Oncol. 2005, 74:157-161.
-
(2005)
Radiother Oncol.
, vol.74
, pp. 157-161
-
-
Astrom, L.1
Pedersen, D.2
Mercke, C.3
Holmang, S.4
Johansson, K.A.5
-
82
-
-
75949114376
-
Feasibility and toxicity of a single fraction high-dose-rate brachytherapy followed by a course of EBRT for localized prostate cancer: a retrospective study. The polyclinique Courlancy experience
-
Mallet F., Wdowczyk D., Bruna A., Villena P., Herard A., Amory J.P., et al. Feasibility and toxicity of a single fraction high-dose-rate brachytherapy followed by a course of EBRT for localized prostate cancer: a retrospective study. The polyclinique Courlancy experience. Cancer Radiother. 2010, 14:11-18.
-
(2010)
Cancer Radiother.
, vol.14
, pp. 11-18
-
-
Mallet, F.1
Wdowczyk, D.2
Bruna, A.3
Villena, P.4
Herard, A.5
Amory, J.P.6
-
83
-
-
79960087306
-
Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer
-
[in press]. doi:10.1016/j.ijrobp.2010.04.046
-
Morton GC, Loblaw DA, Chung H, Tsang G, Sankreacha R, Deabreu A, et al. Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2010; [in press]. doi:10.1016/j.ijrobp.2010.04.046.
-
(2010)
Int J Radiat Oncol Biol Phys
-
-
Morton, G.C.1
Loblaw, D.A.2
Chung, H.3
Tsang, G.4
Sankreacha, R.5
Deabreu, A.6
-
84
-
-
77952573175
-
Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life
-
Morton G.C, Loblaw D.A., Sankreacha R., Deabreu A., Zhang L., Mamedov A., et al. Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life. Int J Radiat Oncol Biol Phys 2010, 77:811-817.
-
(2010)
Int J Radiat Oncol Biol Phys
, vol.77
, pp. 811-817
-
-
Morton, G.C.1
Loblaw, D.A.2
Sankreacha, R.3
Deabreu, A.4
Zhang, L.5
Mamedov, A.6
-
85
-
-
58149490954
-
Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy
-
Ghadjar P., Keller T., Rentsch C.A., Isaak B., Behrensmeier F., Stroux A., et al. Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy. Brachytherapy. 2009, 8:45-51.
-
(2009)
Brachytherapy.
, vol.8
, pp. 45-51
-
-
Ghadjar, P.1
Keller, T.2
Rentsch, C.A.3
Isaak, B.4
Behrensmeier, F.5
Stroux, A.6
-
86
-
-
0036720256
-
Pathologic evidence of dose-response and dose-volume relationships for prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy the predictive value of 2-year posttreatment biopsy after prostate cancer radiotherapy for eventual biochemical outcome prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate ca
-
Kestin L.L., Goldstein N.S., Vicini F.A., Mitchell C., Gustafson G.S., Stromberg J.S., et al. Pathologic evidence of dose-response and dose-volume relationships for prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy the predictive value of 2-year posttreatment biopsy after prostate cancer radiotherapy for eventual biochemical outcome prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial A phase II study of localized prostate cancer treated to 75.6gy with 3D conformal radiotherapy. Int J Radiat Oncol Biol Phys 2002, 54:107-118.
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.54
, pp. 107-118
-
-
Kestin, L.L.1
Goldstein, N.S.2
Vicini, F.A.3
Mitchell, C.4
Gustafson, G.S.5
Stromberg, J.S.6
-
87
-
-
38049120408
-
Measurement of craniocaudal catheter displacement between fractions in computed tomography-based high dose rate brachytherapy of prostate cancer
-
Kim Y., Hsu I.C., Pouliot J. Measurement of craniocaudal catheter displacement between fractions in computed tomography-based high dose rate brachytherapy of prostate cancer. J Appl Clin Med Phys. 2007, 8:2415.
-
(2007)
J Appl Clin Med Phys.
, vol.8
, pp. 2415
-
-
Kim, Y.1
Hsu, I.C.2
Pouliot, J.3
-
88
-
-
1542346475
-
Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy
-
Mullokandov E., Gejerman G. Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy. Int J Radiat Oncol Biol Phys. 2004, 58:1063-1071.
-
(2004)
Int J Radiat Oncol Biol Phys.
, vol.58
, pp. 1063-1071
-
-
Mullokandov, E.1
Gejerman, G.2
-
89
-
-
77449127200
-
A small tolerance for catheter displacement in high-dose rate prostate brachytherapy is necessary and feasible
-
Tiong A., Bydder S., Ebert M., Caswell N., Waterhouse D., Spry N., et al. A small tolerance for catheter displacement in high-dose rate prostate brachytherapy is necessary and feasible. Int J Radiat Oncol Biol Phys. 2010, 76:1066-1072.
-
(2010)
Int J Radiat Oncol Biol Phys.
, vol.76
, pp. 1066-1072
-
-
Tiong, A.1
Bydder, S.2
Ebert, M.3
Caswell, N.4
Waterhouse, D.5
Spry, N.6
-
90
-
-
3042522618
-
Dosimetric impact of prostate volume change between CT-based HDR brachytherapy fractions
-
Kim Y., Hsu I.C., Lessard E., Vujic J., Pouliot J. Dosimetric impact of prostate volume change between CT-based HDR brachytherapy fractions. Int J Radiat Oncol Biol Phys. 2004, 59:1208-1216.
-
(2004)
Int J Radiat Oncol Biol Phys.
, vol.59
, pp. 1208-1216
-
-
Kim, Y.1
Hsu, I.C.2
Lessard, E.3
Vujic, J.4
Pouliot, J.5
-
91
-
-
38149120882
-
HDR prostate monotherapy: dosimetric effects of implant deformation due to posture change between TRUS- and CT-imaging
-
Seppenwoolde Y., Kolkman-Deurloo I.K., Sipkema D., de Langen M., Praag J., Jansen P., et al. HDR prostate monotherapy: dosimetric effects of implant deformation due to posture change between TRUS- and CT-imaging. Radiother Oncol. 2008, 86:114-119.
-
(2008)
Radiother Oncol.
, vol.86
, pp. 114-119
-
-
Seppenwoolde, Y.1
Kolkman-Deurloo, I.K.2
Sipkema, D.3
de Langen, M.4
Praag, J.5
Jansen, P.6
-
92
-
-
72449170492
-
Needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer
-
Yoshida K., Yamazaki H., Nose T., Shiomi H., Yoshida M., Mikami M., et al. Needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer. Brachytherapy 2010, 9:36-41.
-
(2010)
Brachytherapy
, vol.9
, pp. 36-41
-
-
Yoshida, K.1
Yamazaki, H.2
Nose, T.3
Shiomi, H.4
Yoshida, M.5
Mikami, M.6
-
93
-
-
77957191141
-
Trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321
-
Hsu I.C., Kyounghwa B., Shinohara K., Pouliot J., Purdy J., Ibbott G., et al. trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321. Int J Radiat Oncol Biol Phys. 2010, 78:751-758.
-
(2010)
Int J Radiat Oncol Biol Phys.
, vol.78
, pp. 751-758
-
-
Hsu, I.C.1
Kyounghwa, B.2
Shinohara, K.3
Pouliot, J.4
Purdy, J.5
Ibbott, G.6
-
94
-
-
33748271706
-
High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features
-
Vargas C., Martinez A., Galalae R., Demanes J., Harsolia A., Schour L., et al. High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features. Prostate Cancer Prostatic Dis. 2006, 9:245-253.
-
(2006)
Prostate Cancer Prostatic Dis.
, vol.9
, pp. 245-253
-
-
Vargas, C.1
Martinez, A.2
Galalae, R.3
Demanes, J.4
Harsolia, A.5
Schour, L.6
-
95
-
-
77957377537
-
Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT
-
Deutsch I., Zelefsky M.J., Zhang Z., Mo Q., Zaider M., Cohen G., et al. Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT. Brachytherapy. 2010, 9:313-318.
-
(2010)
Brachytherapy.
, vol.9
, pp. 313-318
-
-
Deutsch, I.1
Zelefsky, M.J.2
Zhang, Z.3
Mo, Q.4
Zaider, M.5
Cohen, G.6
-
96
-
-
70350499495
-
Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic review
-
Pieters B.R., de Back D.Z., Koning C.C., Zwinderman A.H. Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic review. Radiother Oncol. 2009, 93:168-173.
-
(2009)
Radiother Oncol.
, vol.93
, pp. 168-173
-
-
Pieters, B.R.1
de Back, D.Z.2
Koning, C.C.3
Zwinderman, A.H.4
-
97
-
-
34548047243
-
High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial
-
Hoskin P.J., Motohashi K., Bownes P., Bryant L., Ostler P. High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial. Radiother Oncol. 2007, 84:114-120.
-
(2007)
Radiother Oncol.
, vol.84
, pp. 114-120
-
-
Hoskin, P.J.1
Motohashi, K.2
Bownes, P.3
Bryant, L.4
Ostler, P.5
|